Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-31
2005-05-31
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S393000, C544S281000, C548S303700
Reexamination Certificate
active
06900216
ABSTRACT:
The present invention relates to certain novel substituted dihydroimidazo[2,1-b]thiazole and dihydro-5H-thiazolo[3,2-a]pyrimidine compounds including pharmaceutically acceptable salts thereof which have an affinity for 5-HT1Areceptors and which inhibit neuronal reuptake of 5-hydroxytryptamine and/or noradrenaline, to processes for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of depression, anxiety, psychoses including schizophrenia, tardive dyskinesia, obesity, drug addiction, drug abuse, cognitive disorders, Alzheimer's disease, obsessive-compulsive behaviour, panic attacks, social phobias, eating disorders such as bulimia, anorexia, snaking and binge eating, non-insulin dependent diabetes mellitus, hyperglycaemia, hyperlipidaemia, stress, as an aid to smoking cessation and in the treatment and/or prophylaxis of seizures, neurological disorders such as epilepsy and/or in which there is neurological damage such as stroke, brain trauma, cerebral ischaemia, head injuries and haemorrhage.
REFERENCES:
patent: WO 94/06789 (1994-03-01), None
patent: WO 97/02269 (1997-01-01), None
patent: WO 98/41528 (1998-09-01), None
patent: WO 00/71548 (2000-11-01), None
patent: WO 00/71549 (2000-11-01), None
International Search Report mailed on Jul. 18, 2001 for International Patent Application PCT/EP 01/02700 filed on Mar. 10, 2001.
Doyle Kevin James
Kerrigan Frank
Watts John Paul
Bromberg & Sunstein LLP
Knoll GmbH
Raymond Richard L.
LandOfFree
Dihydroimidazo[2,1-b]thiazole and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydroimidazo[2,1-b]thiazole and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydroimidazo[2,1-b]thiazole and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3411540